High Mortality During the Second Wave of the Coronavirus Disease 2019 (COVID-19) Pandemic in Uganda: Experience From a National Referral COVID-19 Treatment Unit
dc.contributor.author | Bongomin, Felix | |
dc.contributor.author | Fleischer, Brian | |
dc.contributor.author | Olum, Ronald | |
dc.contributor.author | Natukunda, Barbra | |
dc.contributor.author | Kiguli, Sarah | |
dc.contributor.author | Byakika-Kibwika, Pauline | |
dc.contributor.author | Baruch Baluku, Joseph | |
dc.contributor.author | Nakwagala, Frederick Nelson | |
dc.date.accessioned | 2023-11-30T09:57:22Z | |
dc.date.available | 2023-11-30T09:57:22Z | |
dc.date.issued | 2021-10-18 | |
dc.description.abstract | Background. We evaluated clinical outcomes of patients hospitalized with coronavirus disease 2019 (COVID-19) in the second wave of the pandemic in a national COVID-19 treatment unit (CTU) in Uganda. Methods. We conducted a retrospective cohort study of COVID-19 patients hospitalized at the Mulago National Referral Hospital CTU between May 1 and July 11, 2021. We performed Kaplan-Meier analysis to evaluate all-cause in-hospital mortality. Results. Of the 477 participants, 247 (52%) were female, 15 (3%) had received at least 1 dose of the COVID-19 vaccine, and 223 (46%) had at least 1 comorbidity. The median age was 52 (interquartile range, 41–65) years. More than 80% of the patients presented with severe (19%, n = 91) or critical (66%, n = 315) COVID-19 illness. Overall, 174 (37%) patients died. Predictors of all-cause in-hospital mortality were as follows; age ≥50 years (adjusted odds ratio [aOR], 1.9; 95% confidence interval [CI], 1.2–3.2; P = .011), oxygen saturation at admission of ≥92% (aOR, 0.97; 95% CI, 0.91–0.95; P < .001), and admission pulse rate of ≥100 beats per minute (aOR, 1.01; 95% CI, 1.00–1.02; P = .042). The risk of death was 1.4-fold higher in female participants compared with their male coun terparts (hazards ratio, 1.4; 95% CI, 1.0–2.0; P = .025). Conclusions. In this cohort, where the majority of the patients presented with severe or critical illness, more than one third of the patients hospitalized with COVID-19 at a national CTU died of the illness. | en_US |
dc.description.sponsorship | Fogarty International Center of the National Institutes of Health, US Department of State’s Office of the US Global AIDS Coordinator and Health Diplomacy (S/GAC), and President’s Emergency Plan for AIDS Relief (PEPFAR) under Award Number 1R25TW011213 | en_US |
dc.identifier.citation | Bongomin, F., Fleischer, B., Olum, R., Natukunda, B., Kiguli, S., Byakika-Kibwika, P., ... & Nakwagala, F. N. (2021, November). High mortality during the second wave of the coronavirus disease 2019 (COVID-19) pandemic in Uganda: experience from a national referral COVID-19 treatment unit. In Open Forum Infectious Diseases (Vol. 8, No. 11, p. ofab530). US: Oxford University Press. | en_US |
dc.identifier.other | https://doi.org/10.1093/ofid/ofab530 | |
dc.identifier.uri | https://academic.oup.com/ofid/article/8/11/ofab530/6431007 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14270/405 | |
dc.language.iso | en | en_US |
dc.publisher | Oxford University Press | en_US |
dc.subject | COVID-19; | en_US |
dc.subject | mortality; | en_US |
dc.subject | high-dependency unit; | en_US |
dc.subject | second wave; | en_US |
dc.subject | Uganda. | en_US |
dc.title | High Mortality During the Second Wave of the Coronavirus Disease 2019 (COVID-19) Pandemic in Uganda: Experience From a National Referral COVID-19 Treatment Unit | en_US |
dc.type | Article | en_US |